Today, we are excited to welcome Margaret Keegan (Margaret K.) as our Chief Executive Officer! Margaret is a passionate leader, with over thirty years of relevant, life sciences experience and a deep commitment to our foundational principles, as well as our patient-centric and client-first approach.
Margaret’s vision and extensive industry knowledge will be instrumental as she leads us through our next stage of growth, and we continue to support life sciences organizations in bridging the gap between science and health, by accelerating the development of biomedical innovation and ensuring widespread access to new, breakthrough therapies.
Welcome to the team, Margaret! Read more in our press release: https://lnkd.in/e6XSNSPD
“PMG was among the first to recognize the power of more personalized, targeted therapies to deliver better outcomes, and early to identify the possibilities and challenges that precision medicine-based approaches would introduce from clinical development through commercialization," says Margaret. "In many ways, our industry is at a similar inflection point now, as we assimilate innovations in technology and artificial intelligence and respond to new regulations and shifting macroeconomic conditions. This introduces a tremendous opportunity for PMG to advance from being the first mover in precision medicine to being the global expert in drug development and commercialization. I am thrilled to be joining Precision at this exciting point in the company’s rapid development and look forward to leading this outstanding team of professionals.”
